Letters to the Editor

Germline loss of function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA; Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, V5N 5K9, Canada; Leukemia/BMT Program of BC, BC Cancer, Vancouver, BC, V5N 5K9
Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, 60637
Department of Pathology, The University of Chicago, Chicago, IL, 60637
Department of Pathology, The University of Chicago, Chicago, IL, 60637
Department of Pathology, The University of Chicago, Chicago, IL, 60637
Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA; Department of Human Genetics, The University of Chicago, Chicago, IL, 60637
Haematologica Early view May 4, 2023 https://doi.org/10.3324/haematol.2022.281580